Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database.
Terentes-Printzios D, Dima I, Benardos P, Mitrou P, Mathioudakis K, Tsolakidis A, Barkas F, Tsioufis K, Sfikakis PP, Liberopoulos E, Vlachopoulos C. Terentes-Printzios D, et al. Among authors: dima i. Int J Cardiol Cardiovasc Risk Prev. 2024 Mar 19;21:200261. doi: 10.1016/j.ijcrp.2024.200261. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 38623144 Free PMC article.
The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness.
Terentes-Printzios D, Gardikioti V, Solomou E, Emmanouil E, Gourgouli I, Xydis P, Christopoulou G, Georgakopoulos C, Dima I, Miliou A, Lazaros G, Pirounaki M, Tsioufis K, Vlachopoulos C. Terentes-Printzios D, et al. Among authors: dima i. Hypertens Res. 2022 May;45(5):846-855. doi: 10.1038/s41440-022-00876-6. Epub 2022 Mar 10. Hypertens Res. 2022. PMID: 35273351 Free PMC article. Clinical Trial.
Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
Anagnostis P, Rizos CV, Skoumas I, Rallidis L, Tziomalos K, Skalidis E, Kotsis V, Doumas M, Kolovou G, Sfikas G, Garoufi A, Lambadiari V, Dima I, Kiouri E, Agapakis D, Zacharis E, Antza C, Kolovou V, Koumaras C, Bantouvakis G, Liamis G, Liberopoulos EN. Anagnostis P, et al. Among authors: dima i. Endocrine. 2022 May;76(2):324-330. doi: 10.1007/s12020-022-03013-y. Epub 2022 Mar 9. Endocrine. 2022. PMID: 35262845
LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments.
Rizos CV, Skoumas I, Rallidis L, Skalidis E, Tziomalos K, Garoufi A, Anagnostis P, Sfikas G, Kotsis V, Doumas M, Kolovou G, Lambadiari V, Dima I, Kiouri E, Zacharis E, Agapakis D, Attilakos A, Antza C, Vlachopoulos C, Liberopoulos EN. Rizos CV, et al. Among authors: dima i. Int J Cardiol. 2021 Dec 15;345:119-124. doi: 10.1016/j.ijcard.2021.10.024. Epub 2021 Oct 21. Int J Cardiol. 2021. PMID: 34687802
Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors.
Rallidis LS, Liberopoulos EN, Vlachopoulos C, Skoumas I, Kolovou G, Anastasiou G, Dima I, Tousoulis D, Iliodromitis E. Rallidis LS, et al. Among authors: dima i. Atherosclerosis. 2020 Sep;309:67-69. doi: 10.1016/j.atherosclerosis.2020.07.018. Epub 2020 Jul 30. Atherosclerosis. 2020. PMID: 32859385 No abstract available.
37 results